These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 17982066)

  • 21. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
    Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
    J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients.
    Prange S; Zucker P; Jevnikar AM; Singh B
    Transplantation; 2001 Apr; 71(7):982-5. PubMed ID: 11349735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
    Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
    Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
    Stephens LA; Kay TW
    Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
    Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
    J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of type 1 diabetes in NOD mice by genetic engineering of hematopoietic stem cells.
    Bagley J; Tian C; Iacomini J
    Methods Mol Biol; 2008; 433():277-85. PubMed ID: 18679630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.
    Dai YD; Marrero IG; Gros P; Zaghouani H; Wicker LS; Sercarz EE
    Diabetes; 2009 Jan; 58(1):156-64. PubMed ID: 18984740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
    Reich EP; Sherwin RS; Kanagawa O; Janeway CA
    Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice.
    Formby B; Miller N
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2438-42. PubMed ID: 2138777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans.
    Rajagopalan G; Kudva YC; Chen L; Wen L; David CS
    Int Immunol; 2003 Sep; 15(9):1035-44. PubMed ID: 12917255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exclusive expression of MHC class II proteins on CD45+ cells in pancreatic islets of NOD mice.
    McInerney MF; Rath S; Janeway CA
    Diabetes; 1991 May; 40(5):648-51. PubMed ID: 1827081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.
    Serreze DV; Leiter EH; Shultz LD
    Diabetologia; 1990 Feb; 33(2):84-92. PubMed ID: 2109714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.